CARLSBAD, Calif., Dec. 19, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will webcast the company's presentations at two upcoming investment conferences.
Life Technologies will present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top on Thursday, January 5, 2012 at 4:45pm ET.
Life Technologies will also present at J.P. Morgan 30th Annual Healthcare Conference on Tuesday, January 10, 2012 at 10:30am PT.
Greg Lucier, Life Technologies' Chairman and Chief Executive Officer, will present at both conferences on behalf of the company.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab
in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website:
SOURCE Life Technologies Corporation